OncoTherapy Science Inc. | Cash Flow
Fiscal year is April-March. All values JPY Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
3,715,731.00
1,361,918.00
2,789,446.00
2,997,571.00
2,919,262.00
3,194,655
Depreciation, Depletion & Amortization
99,765.00
106,323.00
125,933.00
89,653.00
148,657.00
391,998
Other Funds
379,367.00
270,525.00
182,129.00
13,903.00
65,801.00
231,090
Funds from Operations
3,236,599.00
1,526,120.00
2,845,642.00
2,921,822.00
2,831,870.00
2,571,567
Changes in Working Capital
1,586,932.00
176,487.00
52,644.00
66,218.00
204,074.00
198,140
Net Operating Cash Flow
1,649,667.00
1,702,607.00
2,898,286.00
2,988,040.00
3,035,944.00
2,373,427
Capital Expenditures
41,282.00
56,284.00
116,643.00
11,957.00
408,888.00
Sale of Fixed Assets & Businesses
138.00
-
-
-
150,000.00
Purchase/Sale of Investments
13,000,000.00
2,000,000.00
10,999,998.00
-
-
Net Investing Cash Flow
13,040,708.00
1,884,414.00
10,883,355.00
11,958.00
296,421.00
Net Financing Cash Flow
11,017,177.00
68,467.00
12,445.00
2,330.00
640.00
Net Change in Cash
3,672,001.00
246,743.00
7,998,486.00
2,997,331.00
3,332,723.00
Free Cash Flow
1,669,219.00
1,748,863.00
3,010,088.00
2,998,794.00
3,444,832.00
Other Sources
436.00
-
-
-
7,677.00
Change in Capital Stock
11,017,177.00
68,467.00
12,445.00
2,330.00
640.00
Exchange Rate Effect
1,197.00
3,531.00
972.00
337.00
995.00
Other Uses
-
59,302.00
-
-
45,210.00
Miscellaneous Funds
-
-
-
-
3.00
About OncoTherapy Science
View Profile
